Cabot (CBT) EBITDA (2009 - 2026)

Cabot (CBT) has 18 years of EBITDA data on file, last reported at $129.0 million in Q1 2026.

• EBITDA for Q1 2026 came in at $129.0 million, down 20.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $60.0 million (down 55.88% YoY), and the FY2025 annual result was $119.0 million, up 7.21% from the prior year.
• EBITDA was little changed at $129.0 million in Q1 2026 per CBT's latest filing, from $129.0 million in the prior quarter.
• Over five years, EBITDA peaked at $172.0 million in Q2 2024 and troughed at -$365.0 million in Q3 2025.
• A 5-year average of $62.1 million and a median of $143.0 million in 2022 frame the typical range for EBITDA.
• The sharpest annual moves came in 2022 and 2023: EBITDA surged 226.51% in 2022, then slumped 302.1% in 2023.
• A 5-year view of EBITDA shows it stood at $105.0 million in 2022, then climbed by 29.52% to $136.0 million in 2023, then gained by 13.97% to $155.0 million in 2024, then decreased by 16.77% to $129.0 million in 2025, then changed by 0.0% to $129.0 million in 2026.
• Business Quant data shows CBT's EBITDA at $129.0 million in Q1 2026, $129.0 million in Q4 2025, and -$365.0 million in Q3 2025.